Strategic partnerships Smirta’s recent collaborations with Tennessee Oncology and OneOncology indicate a momentum in forming strategic, network-wide relationships for OncoSmart platform adoption. This suggests sales opportunities targeting other oncology networks and multi-site practices seeking integrated cancer care optimization.

Clinical ops focus OncoSmart aligns with hospital and clinic operations by optimizing infusion schedules and resource utilization. Target exchanges with cancer centers aiming to improve throughput, reduce wait times, and increase patient capacity could yield high-value contracts.

Digital health traction As a digital health provider with a data-driven platform, Smirta appeals to health systems prioritizing scalable software solutions. There is potential to upsell to larger health networks seeking standardized, cloud-based oncology workflow tools.

R&D & incentives Recent Boast Corp partnership to leverage R&D tax credits signals an openness to collaboration on innovation and cost-saving programs. Propose joint development, grant-aligned pilots, or co-investment opportunities to reduce client acquisition costs.

Mid-market expansion Smirta operates with 11-50 employees and revenue in the 10M-25M range, placing it as a nimble vendor for mid-market oncology groups. Focus outreach on mid-sized cancer centers and regional networks seeking enterprise-grade, quickly deployable scheduling optimization.